Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: Quidel Gets FDA OK for First Pair of Molecular Tests


Quidel in December received 510(k) clearance from the US Food and Drug Administration for two molecular diagnostic tests, the company's first two molecular tests to receive such approval.

First, Quidel received 510(k) clearance for the Quidel Molecular hMPV Assay for detecting human metapneumovirus. Quidel received the CE Mark for the assay in September.

Second, Quidel received FDA marketing clearance for its Molecular Influenza A+B Assay for detecting influenzas A and B. Quidel also launched this product in Europe after receiving the CE Mark in August.

Both assays are part of the Quidel Molecular product line, which consists of PCR reagent kits for use by molecular diagnostic laboratories using Life Technologies' Applied Biosystems 7500 Fast Dx thermocycler. The reagents include features for simple transport and storage, convenient workflow, and a short time to result, among other benefits, Quidel said.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.